Tag Archive for: IVD
China: Molecular Point-of-Care’s International Market to Watch
Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]
2023 Healthcare Trend: Growth in $21 Billion Molecular Diagnostics Market
Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription. The majority […]
127.4 Billion-Dollar IVD Market Blooms
Abbott Leads, Roche Close Second. COVID -19 Tests Largest Share, But Growth Comes from non-COVID The world in vitro diagnostic (IVD) market will reach $127.4 billion dollars in 2022, according to LabPulse.com’s sister publication Kalorama Information. That’s the finding from the firm’s market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition. REPORT: […]
IVD in India: Growing, Aging Population Impacts Healthcare
India, which is expected to surpass China as the most populous country in the world by 2023, has a growing $1,482 million ($1.5 billion) in vitro diagnostics (IVD) industry that is forecast to increase through 2026, as reported by Kalorama Information in the new medical market research study, In Vitro Diagnostics (IVD) in India. The […]
106 Billion IVD Procedures and Counting
“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.” The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]
COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market
“In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information Make no mistake, the in vitro diagnostics (IVD) […]
Cancer IVD: 4 Trends to Watch in $5.5 Billion Market
Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide. Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]
POC Testing Joins “War” on COVID-19 with 45-Minute Cepheid Test
We projected in Kalorama’s mPOC market study that molecular point of care ( mPOC ) would lead the fight in meeting the demand for COVID-19 testing with accurate and fast results. Lab staff is at a premium, hospitals are taxed, and testing needs to happen where it can be useful to isolate patients. We suggested that […]
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
Courtesy of LabPulse.com March 3, 2020 — After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will give Thermo Fisher access to Qiagen’s molecular diagnostics expertise and potentially lead to faster development of diagnostic tests. The deal values Qiagen at 39 euros ($44) per […]
Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- New AACC Guidance Advises Cervical Cancer Testing Strategies for Clinicians and Labs March 10, 2023
- The First Step in Market-Sizing the Molecular Point of Care Market: Defining What it is. March 9, 2023
- Brazil and Mexico Lead IVD Investments in Latin America March 7, 2023
- Still Room to Grow in Infectious Disease IVD March 3, 2023
- China: Molecular Point-of-Care’s International Market to Watch February 21, 2023
Sitemap
Your Data and Privacy
About Us
Visit Science and Medicine Group